Get the app
US › Healthcare

Avantor Inc (AVTR)

US · Healthcare · Medical Instruments & Supplies

$15.47+2.18%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
$1.70B
Revenue YoY
+4.6%
Net profit
$203.4M
EPS
$0.22
EPS estimate
$0.21
Net margin
12.0%

EPS came in at 0.22 against a street estimate of 0.21 — a beat of 4.8%.

Key statistics

Market cap
$10.26B
P/E
31.5
Forward P/E
17.7
P/B
1.81
Book value
$8.61
EPS (TTM)
$0.48
52-week high
$17.45
52-week low
$7.26
50-day MA
$15.56
200-day MA
$11.25
Beta
0.95

Analyst view

Analysts rate Avantor Inc a hold (2 buy, 12 hold, 1 sell out of 15) with an average price target of $17.35.

From the latest earnings call · 2026-10-28

CONFIDENT Avantor returned to organic growth in Q3, exceeded expectations, raised 2026 revenue, EPS and free-cash-flow guidance, and expects leverage below 3x by year-end. Q3 FY26 Management described Americas demand as very strong, Asia as positive, and Europe as behind because of energy costs and government funding pressure. Analysts focused on VWR growth durability, margin pressure, Q4 guidance and AI. Management attributed growth to commercial execution and end-market recovery, while citing mix, inflation and BMP timing headwinds. 2026-10-28…

Full summary in the app.

Shareholding

Insiders
1.54%
Institutions
105.90%

Largest institutional holders

FundStake
Dodge & Cox17.71%
BlackRock Inc10.37%
Vanguard Portfolio Management, LLC4.63%
Vanguard Capital Management, LLC4.55%
Greenhaven Associates Inc3.64%
State Street Corp3.18%
Dimensional Fund Advisors, Inc.3.01%
Engine Capital Management LP2.93%

Recent filings & reports

DocumentDate
Board / officer change · Q4 2026
OTHER NOTABLE POINTS • Avantor approved a special long-term incentive award for Claudius Sokenu, Executive Vice President, Chief Legal and Compliance
2026-11-03
Quarterly report · Q3 2026
HEADLINE NUMBERS • Third-quarter 2026 net sales were $1,698.3 million, up from $1,623.8 million in the third quarter of 2025. • Nine-month 2026 net
2026-10-28
Results announced · Q4 2026
HEADLINE NUMBERS • Q3 2026 net sales were $1,698.3 million, up 4.6% year over year and up 5.2% organically, excluding a 0.6% foreign-currency headwin
2026-10-28
Board / officer change · Q3 2026
AVANTOR, INC. (AVTR) - FORM 8-K SUMMARY HEADLINE NUMBERS • Todd Garner appointed as Executive Vice President and Chief Financial Officer, effective
2026-09-21
Board / officer change · Q3 2026
AVANTOR, INC. - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Todd Garner appointed as Executive Vice President and Chief Financial Officer, effe
2026-09-21
Quarterly report · Q2 2026
AVANTOR, INC. - Q2 2026 FORM 10-Q SUMMARY --- HEADLINE NUMBERS • Net Sales (6M 2026): $3,273.7 million vs. $3,264.8 million (6M 2025) — essentially
2026-07-29
Results announced · Q3 2026
AVANTOR Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net sales: $1,692.3 million, up 0.5% reported; organic decline of 0.4% • Net income: $38.1 milli
2026-07-29
Material agreement · Q3 2026
AVANTOR, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company obtained €374,208,296.62 in new senior secured Euro-denominated term loans on July 14, 2
2026-07-17

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Avantor Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.